La Pefloxacina Nel Trattamento Delle Infezioni Delle Vie Urinarie

1 Barre J. , Houin G. , Tillement J. P. : Dose-dependent pharmacokinetic study of pefloxacin. A new antibacterial agent in humans. J. Pharmacol. Sci., 73; 1379 (1984).

2 Benard Y. , Lemenager J. , Morel C. : Biochemical evaluation of pefloxacin in infectious bronchopulmonary disease. Abst. PS 4.6/4-9, p. 39. XIII Intern. Congr. Chemother., Vienna 1983.

3 Boerema J.B.J. , Klaassen A. G. , Pauwels R.P.E. , Scheepers J. C. , Crombach W.H.J. : Efficacy and safety of pefloxacin in the treatment of urinary tract infections. Abst. WS-7-10, p. 46. 14^th Intern. Congr. Chemother. Kyoto 1985.

4 Brun-Buisson C.J.L. , Rapin M. , Leclercq R. , Soussy C.J. , Duval J. : Pefloxacin as a substitute to conventional therapy in uncontrolled staphyl. aureus infections. Abst. S-52-9, p. 202. 14^th Intern. Congr. Chemother., Kyoto 1985.

5 Desplaces M. , Gutman L. , Acar J.F. : Twice-daily oral therapy for chronic staphylococcal osteitis (CSO) with a new quinolone pefloxacin (PEF) alone and in combination with Rifampicin (RIE). Abst. 279, p. 140. IAAC 1984.

6 Desplaces M. , Gutman L. , Acar J.F. : Treatment of chronic osteomyelitis due to staphylococcus spp. or Gram-negative bacteria with a new quinolone: pefloxacin Abst S-52-10, p. 202. 14^th Intern. Congr. Chemother., Kyoto 1985.

7 Fass R. J. : The quinolones. Ann. intern. Med 102; 400 (1985).

8 Gaillot G. , Frydman A. , Le Roux Y. , Fourtillan J. B. , Lefebvre M. A. , Duchier J. , Djebbar F. : Pharmacokinetics of pefloxacin in man during a repeated treatment (400 mg b.i.d.) with i.v. infusion. Abst. PS 4.6/4-5, p. 18. XIII Intern. Congr. Chemother. Vienna 1983.

9 Guibert J. , Bouteher R. : Pefloxacin (1589 RB): clinical assessment in urinary tract infections’. Abst. PS 4.6/4-12, p. 52. XIII Intern. Congr. Chemother., Vienna 1983.

10 Harms E. , Degner-Harms I. : Effectiveness of pefloxacin in severe female genital tract infections. Abst WS-7-12, p. 46. 14^th Intern. Congr. Chemother., Kyoto 1985.

11 Lauwers S. , Vincken W. , Maessens A. , Pierard D. , Vrije A. Z. : The efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units. Abst. WS-7-11, p. 46. 14^th Intern. Congr. Chemother., Kyoto 1985.

12 Lennette E. H. , Spaulding E. H. , Truant J. P. : Manual of clinical microbiology. Amer. Soc. Microbiol, Washington, D.C. 1980.

13 Lhoste F. : Pefloxacin in severe infections: a multicentre study. Abst. WS-7-13, p 46 14^th Intern. Congr Chemother., Kyoto 1985.

14 Montay G. Goueffon Y. , Roquet F. : Absorption, distribution, metabolic fate and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys and humans. Antimicrob. Agents Chemother., 25; 463 (1984).

15 Peixoto S. , Czeresnia C. E. , Santos N. C. , Menoes C. M. F. , Tomioka E. , Souza A. Z. : Efficacy and safety of pefloxacin in the treatment of severe gynecological infections. Abst. WS-7-14, p. 46. 14^th Intern. Congr. Chemother., Kyoto 1985.

16 Tripi M. , Tulumello S. , Corselli G. , Giammanco A. , Pavone-Macaluso M. : Infezioni delle vie urinarie. Germi responsabili e chemioresistenza negli anni 1978-1983. Urologia. 52; 335 (1985).

17 Wittenberger R. , Bauernfeind A. : Treatment of urinary tract infections with pefloxacin: efficacy safety and pharmacokinetics. Abst. P-12-39, p. 306. 14^th Intern. Congr. Chemother., Kyoto 1985.

18 Wolff M. , Vittecoq D. , Regnier B. , Modai J. , Vachon F. Sarrazin C. , Bure A. : Preliminary trial of pefloxacin in the treatment of urinary tract infections and in seriously ill patients treated in hospital. Abst. PS 4.6/4-14, p. 50. XIII Intern. Congr. Chemother., Vienna 1983.